Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI)

Historical Holders from Q2 2024 to Q3 2025

Symbol
CLDI on NYSE
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
33,630,240
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
21,074
Holdings value
$31,797
% of all portfolios
0%
Number of holders
2
Number of sells
-34
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 9.99% $1,679,830 3,359,661 Armistice Capital, LLC 31 Mar 2025

Institutional Holders of Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 21,074 $31,797 -$953,915 $1.05 2
2025 Q2 2,855,505 $655,824 -$657,230 $0.23 35
2025 Q1 5,458,730 $3,091,541 +$2,351,586 $0.5662 35
2024 Q4 1,102,228 $1,266,731 +$901,052 $1.15 33
2024 Q3 318,770 $363,396 +$331,789 $1.14 19
2024 Q2 156,566 $31,312 +$31,312 $0.2 2